Qinghai Spring Medicinal Resources Technology Co Ltd (600381) — Financial Flexibility Index
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a Financial Flexibility Index of -0.11x as of September 2025. Free cash flow of CN¥-4.77 Million (operating CF CN¥-8.22 Million minus capex CN¥3.45 Million) represents 0% of total liabilities (CN¥45.34 Million). Check 600381 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Qinghai Spring Medicinal Resources Technology Co Ltd Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Qinghai Spring Medicinal Resources Technology Co Ltd across 27 annual periods. See Qinghai Spring Medicinal Resources Techn current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Qinghai Spring Medicinal Resources Technology Co Ltd (1999–2025)
Year-by-year free cash flow to debt coverage for Qinghai Spring Medicinal Resources Technology Co Ltd. For the full company profile including market capitalisation, see Qinghai Spring Medicinal Resources Techn (600381) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.44x | CN¥-19.86 Million | CN¥-26.41 Million | CN¥44.87 Million | ▼ -166.0% |
| 2024 | 0.67x | CN¥85.90 Million | CN¥80.97 Million | CN¥128.02 Million | ▲ +64.8% |
| 2023 | 0.41x | CN¥37.45 Million | CN¥23.92 Million | CN¥91.99 Million | ▲ +134.5% |
| 2022 | -1.18x | CN¥-31.00 Million | CN¥-31.82 Million | CN¥26.30 Million | ▼ -156.3% |
| 2021 | 2.09x | CN¥57.86 Million | CN¥-63.93 Million | CN¥27.64 Million | ▲ +139.8% |
| 2020 | 0.87x | CN¥119.68 Million | CN¥-77.95 Million | CN¥137.08 Million | ▲ +107.6% |
| 2019 | -11.47x | CN¥-231.01 Million | CN¥-236.30 Million | CN¥20.14 Million | ▼ -330.3% |
| 2018 | -2.67x | CN¥-140.46 Million | CN¥-183.97 Million | CN¥52.68 Million | ▼ -360.0% |
| 2017 | 1.03x | CN¥116.47 Million | CN¥95.74 Million | CN¥113.56 Million | ▼ -42.7% |
| 2016 | 1.79x | CN¥370.41 Million | CN¥344.99 Million | CN¥206.95 Million | ▼ -25.1% |
| 2015 | 2.39x | CN¥847.42 Million | CN¥832.17 Million | CN¥354.60 Million | ▲ +7496.8% |
| 2014 | 0.03x | CN¥35.45 Million | CN¥-89.64 Million | CN¥1.13 Billion | ▼ -6.4% |
| 2013 | 0.03x | CN¥48.38 Million | CN¥-28.09 Million | CN¥1.44 Billion | ▲ +112.3% |
| 2012 | -0.27x | CN¥-520.85 Million | CN¥-701.18 Million | CN¥1.90 Billion | ▼ -195.7% |
| 2011 | 0.29x | CN¥463.38 Million | CN¥249.98 Million | CN¥1.62 Billion | ▼ -39.8% |
| 2010 | 0.48x | CN¥446.18 Million | CN¥71.47 Million | CN¥938.58 Million | ▲ +259.0% |
| 2009 | 0.13x | CN¥69.60 Million | CN¥39.16 Million | CN¥525.60 Million | ▲ +125.6% |
| 2008 | 0.06x | CN¥34.57 Million | CN¥20.83 Million | CN¥589.02 Million | ▲ +492.3% |
| 2007 | 0.01x | CN¥7.01 Million | CN¥7.00 Million | CN¥707.61 Million | ▼ -60.3% |
| 2006 | 0.02x | CN¥21.57 Million | CN¥21.57 Million | CN¥863.38 Million | ▼ -84.0% |
| 2005 | 0.16x | CN¥162.95 Million | CN¥162.12 Million | CN¥1.05 Billion | ▲ +308.7% |
| 2004 | 0.04x | CN¥46.68 Million | CN¥33.83 Million | CN¥1.22 Billion | ▼ -71.8% |
| 2003 | 0.14x | CN¥106.92 Million | CN¥1.43 Million | CN¥789.85 Million | ▼ -35.0% |
| 2002 | 0.21x | CN¥86.57 Million | CN¥15.54 Million | CN¥415.90 Million | ▲ +24.4% |
| 2001 | 0.17x | CN¥44.34 Million | CN¥-10.64 Million | CN¥264.94 Million | ▼ -32.6% |
| 2000 | 0.25x | CN¥46.65 Million | CN¥4.52 Million | CN¥187.91 Million | ▼ -74.0% |
| 1999 | 0.95x | CN¥122.21 Million | CN¥70.28 Million | CN¥128.04 Million | — |